Slow-virus transfection for bone mesenchymal stem cells of machin
A technology of bone marrow mesenchyme and virus transfection, which is applied in the field of virus transfection efficiency of cells, can solve the problems of inability to study and reduce transfection efficiency, and achieve the effect of improving efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1 and comparative example 1 and 2
[0029] The inventor used lentivirus as a vector to transfect cynomolgus monkey mesenchymal stem cells. In Example 1, the cells used were adult cynomolgus monkey cells infected with simian foamy virus. , Stop using the antiretroviral drug Tenofovir on 6 and 8 days, that is, replace the medium 2, 4, 6 and 8 days before lentiviral transfection, and the replaced medium does not contain the antiretroviral drug Tenofovir Nofovir; in Comparative Example 1, the cells used were adult cynomolgus monkey cells infected with simian foamy virus, and the antiretroviral drug tenofovir was not stopped during the transfection process with lentivirus; In comparative example 2, the cells used were cynomolgus monkey cells not infected with simian foamy virus (these cynomolgus monkey cells were taken from young cynomolgus monkeys aged 1-3, and the experimental animal cynomolgus monkeys came from Lingkangsai, Nanning, Guangxi Nuoke Biotechnology Co., Ltd., the company's animal experiment facilities ...
Embodiment 1
[0049] The adult cynomolgus monkey bone marrow mesenchymal stem cells used in Example 1 and Comparative Example 1 were cryopreserved cells by the inventor, and were obtained from adult cynomolgus monkeys (these cynomolgus monkeys were from Lingkang Sanuoke Biotechnology Co., Ltd., Nanning, Guangxi). Co., Ltd., the company's animal experiment facilities have obtained the qualification certification of the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC), these cells have been used in the culture process before cryopreservation containing Thai Nofovir medium, if you use resuscitated adult cynomolgus bone marrow mesenchymal stem cells, stop using tenofovir after resuscitation, that is, use a medium without tenofovir, respectively, on the 2nd day after resuscitation. , 4, 6, and 8 days for viral transfection (referring to four parallel experiments for viral transfection at different time points, equivalent to discontinuing Tenofo on days 2, 4, 6, and ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 